Interpace Biosciences, Inc. (IDXG)
1.80
0.00 (0.00%)
USD |
OTCM |
May 20, 15:54
Interpace Biosciences Free Cash Flow : 4.382M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Biodesix, Inc. | -25.27M |
| FONAR Corp. | 4.167M |
| Thermo Fisher Scientific, Inc. | 6.748B |
| Innovative MedTech, Inc. | -- |
| Meridian Holdings, Inc. (California) | 0.00 |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 0.283M |
| Cash from Investing (Quarterly) | -0.141M |
| Free Cash Flow Per Share (Quarterly) | 0.0051 |
| Free Cash Flow to Equity (Quarterly) | 0.245M |
| Free Cash Flow to Firm (Quarterly) | 0.142M |
| Free Cash Flow Yield | 11.13% |